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Abstract According to the 'shuttle hypothesis', vasopressin in- 
creases the water permeability of renal epithelial cells by exocy- 
totic fusion of vesicles containing the water channel AQP-CD 
with the apical plasma membrane, whereas withdrawal of vaso- 
pressin results in endocytotic uptake of AQP-CD. The proteins 
involved in the redistribution of AQP-CD have not been identi- 
fied. With a panel of monoclonal antibodies, we detected Rab3-, 
Rab5a- and synaptobrevin II-like proteins in a kidney preparation 
enriched in AQP-CD-containing vesicles. The synaptobrevin II- 
like protein is not identical with the ubiquitous cellubrevin. Rab3- 
and synaptobrevin II- but not RabSa-like proteins were co-en- 
riched with AQP-CD. The data suggest hat the proteins involved 
in hormonal regulation of water permeability in kidney epithelial 
cells are identical or similar to those involved in regulated exocy- 
tosis in secretory cells. 
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1. Introduction 
The peptide hormone vasopressin, also referred to as antidi- 
uretic hormone, is the key regulator of water homeostasis n
mammals. The main site of vasopressin action is the renal 
collecting duct. Vasopressin binds to V2 receptors [1] expressed 
on the basolateral surface of epithelial (principal) cells and, 
acting via the adenylyl cyclase cascade, increases the water 
permeability of the apical plasma membrane. This permits the 
reabsorption of water from the lumen of the collecting duct. 
Water transport across epithelia is mediated by intrinsic 
membrane proteins (aquaporins, AQPs), which form selective 
channels for water molecules (for review see [2]). The first AQP 
to be cloned was AQP-CHIP, a highly abundant protein in 
erythrocyte membranes [3]. In the kidney, AQP-CHIP, located 
in epithelial cells of the proximal tubule and of the descending 
loop of Henle, seems to be required for constitutive water 
transport [2]. AQP-CD (formerly called WCH-CD) is exclu- 
sively located in the renal collecting duct [4]. The cellular distri- 
bution of AQP-CD and the finding that inactivating mutations 
are associated with an atypical form of congenital nephrogenic 
diabetes insipidus [5] provide strong evidence that AQP-CD is 
the vasopressin-regulated AQP. AQP-CD is the only known 
water-channel xhibiting fast hormonal regulation. 
*Corresponding author. Fax: (49) (641) 702 7390. 
Abbreviations: AQP-CD, aquaporin-collecting duct; GTPS, guanosine 
5'-[~'-thio]triphosphate. 
The molecular mechanisms of the vasopressin-induced in- 
crease in water permeability of principal cells are poorly under- 
stood. According to the 'shuttle hypothesis' (for reviews see 
[6,7]), vasopressin increases water permeability by exocytotic 
insertion of water channels in the apical membrane. This hy- 
pothesis is strongly supported by the recent finding that AQP- 
CD is associated with the apical plasma membrane and with 
subapical and perinuclear vesicles of principal cells [8]. In agree- 
ment with previous reports, Harris et al. [9] have shown that 
specific endosomal vesicles from collecting duct epithelia con- 
tain AQP-CD. This observation isconsistent with a redistribu- 
tion of apical water channels into specialized vesicles upon 
removal of vasopressin stimulation. Together, the data support 
the idea that AQP-CD-containing vesicles undergo hormone- 
controlled exo-/endocytosis, resembling regulated exo-/endocy- 
tosis in nerve terminals. 
In recent years considerable progress has been made in eluci- 
dating the molecular mechanisms underlying the assembly, 
docking and fusion of vesicles serving intracellular transport 
and exocytosis. A basic docking/fusion machinery appears to 
be operating in all cells [10]. Additional components seem to 
be required to determine the nature of the docking/fusion proc- 
ess (e.g. exocytosis versus endocytosis, constitutive xocytosis 
versus regulated exocytosis). For example, proteins of the Rab3 
and Rab5 families are specifically linked to regulated exocytosis 
and to endocytosis, respectively [11]. 
To gain insight into the vasopressin-regulated increase in 
water permeability, we looked for proteins involved in vesicular 
transport in a preparation from rat kidney enriched in AQP- 
CD containing vesicles. The present data show that this prepa- 
ration contains proteins detected by an antibody which recog- 
nizes Rab3a, b and c and by antibodies pecific for Rab5a and 
synaptobrevin II. The identification of immunoreactive pro- 
teins in the vesicle preparation strongly indicates that vaso- 
pressin regulates water permeability by exo-/endocytotic mech- 
anisms similar to those in secretory cells. 
2. Materials and methods 
2.1. Materials 
Phenylmethylsulfonyl fluoride, soybean trypsin inhibitor, aprotinin 
and benzamidine were from Sigma (Miinchen, FRG), recombinant 
N-glycosidase F from Boehringer (Mannheim, FRG), Percoll from 
Pharmacia (Freiburg, FRG), nitrocellulose membranes from Schleicher 
and Schuell (Dassel, FRG), ~25I-labeled donkey anti-rabbit IgG (185- 
740 kBq/pg) and ECL (enhanced chemiluminescence) W stern-blotting 
detection system from Amersham Buchler (Braunschweig, FRG), and 
~25I-labeled goat anti-mouse IgG (74-370 kBq/pg) from DuPont (Bad 
Homburg, FRG). 
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2.2. Antisera 
For the generation of polyclonal antisera gainst AQP-CD a syn- 
thetic peptide (VELHSPQSLPRGSKA) corresponding to the 15 C- 
terminal amino acids of AQP-CD with an additional N-terminal tyro- 
sine residue [4] was coupled to keyhole limpet hemocyanine and used 
for the immunization of rabbits. 
The following antibodies, kindly provided by Reinhard Jahn (New 
Haven, CT), were employed: antibody C142.1 recognizes Rab3a, b and 
c; it is not known whether the antibody also detects Rab3d ([12] and 
Reinhard Jahn, personal communication); antibody CI 621.2 recog- 
nizes Rab5a only ([13] and Reinhard Jahn, personal communication); 
antibody C1 69.1 recognizes ynaptobrevin II [14], antibody C1 10.1 
recognizes cellubrevin and synaptobrevins I and I1 [15]; antibody CI 
41.1 recognizes synaptotagmin I [16]; antibody CI 43.1 recognizes yn- 
aptophysin [17]. 
2.3. Purification of AQP-CD-containing vesicles from rat renal inner 
medulla nd papilla 
Isolation of AQP-CD-containing vesicles was performed according 
to Harris et al. [9] with minor modifications. All steps were performed 
at 4°C, and all buffers were supplemented with a mixture of protease 
inhibitors (0.5 mM PMSF, 3.2/~g/ml soybean trypsin inhibitor, 2.8 
Jlg/ml aprotinin, 1 mM benzamidine). The inner medullae and papillae 
from 20 rat kidneys were minced and homogenized by 10-15 strokes 
in buffer A (300 mM mannitol, 12 mM HEPES, pH 7.6) using a 
glass/teflon homogenizer. The homogenate was centrifuged at2,500 x g 
lbr 20 rain. The supernatant was centrifuged at 20,000 x g for 20 min. 
The resulting supernatant and the upper layer of the pellet were com- 
bined, and centrifuged at48,000 x g for 30 min. The resulting pellet was 
resuspended in buffer A, homogenized with 30 strokes, and Percoll was 
added to 18% (wt/wt). The suspension was centrifuged at 48,000 x g for 
30 min; the bottom one-third was collected and diluted with an 8-fold 
volume of buffer B (300 mM mannitol, 100 mM KCI, 5 mM MgSO4, 
5 mM HEPES, pH 7.6). After incubation for 15 min, the suspension 
was centrifuged at 48,000 x g for 30 min. The pellet was resuspended 
in buffer B and recentrifuged at5,000 x g for 15 rain. The supernatant 
was discarded and the fluffy upper part of the pellet, containing renal 
papillary and medullary vesicles, was carefully separated from the 
brown bottom pellet and resuspended in buffer B. The yield from 20 
kidneys was about 1 mg of protein. The preparation was stored at 
-80°C. 
The activity of Na+/K+-ATPase, mployed as marker enzyme for the 
basolateral plasma membrane, was determined by a coupled spectro- 
photometric assay in the absence or presence of ouabain as described 
[18]. 
2.4. Preparation of membranes 
All procedures were performed at 4°C. Membranes from kidney 
medulla and papilla were prepared according to Kinne-Saffran and 
Kinne [19] with minor modifications. Briefly, the dissected tissue was 
homogenized with a glass/teflon homogenizer in a buffer consisting of 
250 mM sucrose, 10 mM triethanolamine/HC1 (pH 7.6) and centrifuged 
at 700 x g for 10 min. The supernatant was centrifuged at10,000 x g for 
10 min. The supernatant and the homogenized pellet were recombined 
and centrifuged at 100,000 x g for 60 min. The pellet was resuspended 
in the buffer described above. 
N-glycosidase F digestion was performed according to the manu- 
facter's protocol. Briefly, the membrane pellet (see above) was resus- 
pended in a buffer consisting of 50 mM EDTA, 10 mM NAN,, 1% SDS 
and 20 mM sodium phosphate (pH 7.2). Aliquots (50 Hg of protein in 
10/A) were boiled for 2 min. Ninety/A of the same buffer supplemented 
with 0.5% Nonidet P-40 but without SDS were added and the sample 
was again boiled for 2 min. N-glycosidase F (1 unit) was added, and 
the sample was incubated for 20 h at 37°C. Samples were precipitated 
with acetone before analysis by SDS PAGE/immunoblotting. 
Rat brain was homogenized by 10 strokes with a glass/teflon homog- 
enizer in a buffer consisting of 1 mM EDTA, 0.25 mM DTT and 10 
mM HEPES (pH 7.4) and centrifuged at 10,000 xg for 15 min. The 
supernatant was centrifuged for 90 min at 120,000 x g. The resulting 
pellet was resuspended in the same buffer and stored at -80°C. 
L cells (mouse fibroblasts) were cultured in Dulbecco's modified 
Eagle medium containing 10% heat-inactivated fetal bovine serum, 
penicillin (100 units/ml) and streptomycin (100/zg/ml). For preparation 
of a crude membrane fraction, cells were rinsed twice with phosphate- 
buffered saline consisting of 137 mM NaC1, 2.7 mM KC1, 10 mM 
Na2HPO4 and 1 mM KH2PO4 (pH 7.4), scraped off the dishes and 
centrifuged at 200 x g for 5 min. The pellet was resuspended in a buffer 
consisting of 27% (w/v) sucrose, 1 mM EDTA, 20 mM HEPES (pH 7.8) 
and homogenized with 10 strokes in a glass/teflon homogenizer. The 
pellet obtained by centrifugation at 20,000 x g for 10 min was resus- 
pended in phosphate-buffered saline. The preparation was stored at 
-80°C. 
2.5. lmmunoblotting 
Immunoblotting was performed as described [20]. Briefly, proteins 
were resolved by SDS PAGE (30-60 /zg/lane, 12 or 15% poly- 
acrylamide) and transferred onto nitrocellulose filters. The filters were 
blocked by incubation with Tris-buffered saline (137 mM NaC1, 0.01% 
sodium azide, 10 mM Tris-HC1, pH 7.5) supplemented with 1% (v/v) 
gelatin and 1% (w/v) ovalbumin, and antisera were added for 2 to 12 h. 
t25I-labeled anti-mouse IgG or ~25I-labeled anti-rabbit IgG were used as 
second antibodies. Filters were autoradiographed for 1-3 days. De- 
tection of proteins with antibody CI 10.1 was performed with the ECL 
Western-blotting system according to the manufacterer's protocol. 
2.6. Protein determination 
Protein was measured according to Lowry et al. [21]. 
3. Results 
A polyclonal antibody was raised against the C-terminal 
peptide sequence of the rat water channel AQP-CD [4]; this 
sequence does not occur in any other AQE The properties of 
the antibody are very similar to those of previously described 
antibodies raised against he same epitope (e.g. [8,9]). In mem- 
branes from rat kidney inner medulla and papilla, the antibody 
but not the preimmune-serum labeled a broad band at 35 to 40 
kDa, a narrow band at 29 kDa and material above 94 kDa 
(most likely representing large aggregates of AQP-CD) (Fig. 
1A). Labeling was abolished by preincubation of the antiserum 
with the synthetic peptide, indicating the presence of the anti- 
gen in all immunoreactive bands. The assumption that the 
high-molecular-weight material represents aggregates of AQP- 
CD is further supported by the finding that AQP-CD has a 
marked tendency to aggregate ven in the presence of SDS 
(unpublished). Fig. IB shows that staining of the 35-40 kDa 
band is significantly reduced by treatment with the enzyme 
N-glycosidase F. This finding indicates that the 35-40 kDa 
band and the 29 kDa band represent he glycosylated and 
nonglycosylated forms of AQP-CD, respectively. Also consis- 
tent with previous reports [8,9], AQP-CD was found to be more 
abundant in the inner medulla/papilla than in the cortex (Fig. 
1C). The antibody failed to detect proteins in either human 
erythrocyte membranes (a rich source for AQP-CHIP) or cell 
lines (CHO, L) expressing functional water channels (not 
shown). The data indicate that the antibody specifically recog- 
nizes AQP-CD. 
For further studies, AQP-CD-containing vesicles were puri- 
fied from rat kidney medulla/papilla ccording to a recently 
published method [9]. To check for contamination with baso- 
lateral membranes, Na+/K+-ATPase activity was determined in 
both the starting material (homogenate) and the vesicle prepa- 
ration; three independent preparations were tested. Whereas 
activity was present in the homogenate (0.19 + 0.04 U/mg pro- 
tein; mean _+ S.D.), no activity was detectable in the vesicle 
preparation. This finding is consistent with the absence of baso- 
lateral membranes in the vesicle preparation and indicates that 
the vesicles are not of basolateral origin. Fig. 2A shows that 
AQP-CD is several-fold enriched in the vesicle preparation 
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Fig. 1. Characterization of an antibody raised against a synthetic peptide specific for AQP-CD. Various AQP-CD-containing preparations (60 pg 
of protein per lane) were analyzed by SDS PAGElimmunoblotting. Preimmune serum or anti-AQP-CD antiserum was employed at a 1: 1,000 dilution. 
Filter-bound antibody was labeled with ‘*‘I anti rabbit IgG antibody. Shown are autoradiograms of filters. (A) Filters from rat inner medulla/papilla 
(IM/P) were incubated with preimmune-serum (C), anti-AQPCD antiserum (AS), or anti-AQP-CD antiserum preincubated with the peptide 
immunogen (35 &ml; AS + P). (B) Prior to SDS PAGE/immunoblotting with anti-AQP-CD antiserum, membrane aliquots from IM/P were 
incubated without (-) or with N-glycosidase F (+). (C) Membrane aliquots from IM/P or outer medulla (OM) were analyzed by SDS PAGE/ 
immunoblotting with anti-AQP-CD antiserum. 
compared to the homogenate. A panel of monoclonal antibod- 
ies (see section 2) was employed to search for proteins known 
to be involved in vesicular transport. Fig. 2B shows that these 
antibodies recognize their antigens Rab3 (27 kDa), Rab5a (27 
kDa), synaptobrevin II (18 kDa), synaptotagmin I (65 kDa) 
and synaptophysin (38 kDa) in rat brain membranes. In the 
vesicle preparation from rat kidney, proteins were detected by 
Rab3, Rab5a and synaptobrevin II antibodies but not by the 
synaptotagmin I and synaptophysin antibodies. The mobilities 
of the immunoreactive proteins in the brain and kidney prepa- 
rations were indistinguishable, suggesting that the proteins are 
identical or at least very similar. The antibody against synap- 
tobrevin II does not recognize the ubiquitous synaptobrevin 
homologue, cellubrevin [22]. Hence the immunoreactive pro- 
tein in the kidney preparation is not cellubrevin. 
Together with AQP-CD, the Rab3- and synaptobrevin 
II-like proteins were enriched during the course of vesicle puri- 
fication (Fig. 3). These findings are consistent with a localiza- 
tion of Rab3- and synaptobrevin II-like proteins on AQP-CD- 
containing vesicles. In contrast, the RabSa-like protein was not 
enriched. Among the various antibodies, only the Rab5a anti- 
body detected a protein in L cells, reflecting the occurrence of 
the protein in both secretory and non-secretory cells [23]. 
By binding of [35S]GTPyS to proteins immobilized onto ni- 
trocellulose, proteins of about 27 kDa, most likely correspond- 
ing to members of the Rab family, and a protein of 20 kDa were 
B. 
a 
kDa 
94- 
67 - 
43- 
4m 
30 ----(I, 
Fig. 2. Detection of Rab3-, RabSa- and synaptobrevin II-like proteins in AQP-CD-containing vesicles. Proteins were analyzed by SDS PAGE/ 
immunoblotting with the indicated antibodies. Filter-bound antibodies were labeled with ‘*‘I anti rabbit or anti mouse IgG antibody. Shown are 
autoradiograms of filters. (A) Equal amounts of protein (6Opg per lane) from homogenate (lane 1) and AQP-CD-containing vesicles (lane 2) prepared 
from rat kidney medulla/papilla were analyzed by SDS PAGElimmunoblotting with anti-AQP-CD antiserum. (B) Rat brain membranes (lanes 1, 
3Opg of protein) and AQP-CD-containing vesicles from kidney medulla/papilla (lanes 2,6Opg of protein) were analyzed by SDS PAGElimmunoblot- 
ting with monoclonal antibodies specific for Rab3 (Cl 42.1) Rab5a (Cl 621.2) synaptobrevin II (Cl 69. l), synaptophysin (Cl 43.1) and synaptotagmin 
I (Cl 41.1). 
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prominently abeled in the vesicle preparation ( ot shown). The 
data suggest hat AQP-CD-containing vesicles possess other 
small GTP-binding proteins in addition to Rab proteins. 
We also employed an antibody (C1 10.1), which recognizes 
synaptobrevins I and II and cellubrevin (see section 2). Short 
exposure of filters (Fig. 4A) revealed that this antibody recog- 
nizes two bands in brain membranes. The upper band comi- 
grated with the protein recognized by the antibody specific for 
synaptobrevin II (not shown). Thus the upper band recognized 
by antibody C1 10.1 is tentatively identified as synaptobrevin 
II, whereas the lower band may represent synaptobrevin I and 
cellubrevin, the latter being of non-neuronal origin (glia, ves- 
sels). Resolution of the two bands is lost after the long exposure 
required for detection of proteins in kidney and L cell prepara- 
tions (Fig. 4B). In starting material from kidney inner medulla/ 
papilla, a protein comigrating with the lower band visible in 
Fig. 4A is stained by the antibody. In the preparation enriched 
in AQP-CD-containing vesicles an additional band comigrating 
with the upper band visible in Fig. 4A is detected. This band 
most likely represents the synaptobrevin II-like protein. In L 
cells, a band comigrating with the lower band visible on Fig. 
4A is detected; this band may represent cellubrevin. In this cell 
line the antibody recognizes an additional protein of 12 kDa; 
the nature of this protein is unknown. The data are consistent 
with the view that the synaptobrevin II-like protein but not 
cellubrevin isenriched uring the course of vesicle preparation. 
They provide additional independent evidence for the notion 
(see above) that the synaptobrevin II-like protein is not identi- 
cal with cellubrevin. 
4. Discussion 
In this report we show that a preparation from rat kidney 
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Fig. 3. Enrichment of Rab3-, Rab 5- and synaptobrevin II-like proteins 
during the course of purification of AQP-CD-containing vesicles. Pro- 
teins were analyzed by SDS PAGE/immunoblotting with the indicated 
monoclonal ntibodies against Rab3 (C1 42.1), Rab 5a (C1 621.2) and 
synaptobrevin II (C1 69.1) and with ~25I anti mouse IgG antibody. 
Shown are autoradiograms of filters. The following preparations were 
analyzed: lanes 1, rat brain (30pg of protein); lanes 2, homogenate from 
rat kidney medulla/papilla (60/lg of protein), lanes 3, AQP-CD-con- 
taining vesicles from rat kidney medulla/papilla (60,ug of protein); lanes 
4, membranes from L cells (60/.tg of protein). 
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Fig. 4. Detection of proteins by a monoclonal antibody recognizing 
synaptobrevin I, synaptobrevin II and cellubrevin i  preparations from 
rat brain, rat renal medulla/papilla and L cells. Proteins were analyzed 
by SDS PAGE/immunoblotting with the monoclonal antibody CI 10.1. 
Filter-bound antibodies were visualized with the ECL system. (A) Rat 
brain membranes (30/~g of protein) were employed. The exposure time 
was 15 s. (B) The following preparations were analyzed: lane 1, rat brain 
membranes (30/lg of protein); lane 2, homogenate from rat kidney 
medulla/papilla (60/.tg of protein); lane 3, AQP-CD-containing vesicles 
from rat kidney medulla/papilla (60 pg of protein); lane 4, membranes 
from L cells (60/lg of protein). The exposure time was three minutes 
(compare with the exposure time in panel A). 
medulla/papilla enriched in AQP-CD-containing vesicles also 
contains a protein of the Rab3 family and a Rab5a- and a 
synaptobrevin II-like protein. Previous studies revealed the 
presence of mRNA for Rab5 but failed to detect mRNA for 
Rab3 and synaptobrevins in total kidney mRNA ([23] and refs. 
cited therein, [24]). In contrast o Rab3 proteins expressed in 
cells exhibiting regulated exocytosis, Rab5 proteins are found 
in cells both with and without regulated exocytosis [11]. In 
agreement with Zahraoui et al. [23], a Rab5-1ike protein was 
also detected in L cells. Besides its presence in neuronal cells, 
synaptobrevin II has recently been detected in rat skeletal mus- 
cle and in L6 myotubes, and synaptobrevin-like molecules are 
present in adipocytes and pancreatic acinar cells ([25] and refs. 
cited therein). The apparent absence of synaptotagmin I and 
synaptophysin from the vesicle preparation precludes contami- 
nation with material from peripheral nerves as a source of 
Rab3- and synaptobrevin II-like proteins. 
The detection of Rab3- and synaptobrevin II-like proteins in 
the vesicle preparation and their enrichment during the course 
of purification of AQP-CD-containing vesicles is of particular 
interest. Rab3 proteins in neuronal and neuroendocrine c lls 
appear to be crucially involved in the fusion of secretory vesi- 
cles with the plasma membrane [26]. The identified Rab3-1ike 
protein may serve a similar function in kidney epithelial cells. 
In analogy to the intracellular localization and role of synap- 
tobrevins in neuronal cells, the synaptobrevin II-like protein in 
the kidney may be a part of the essential docking/fusion ma- 
chinery of AQP-CD-containing, regulated vesicles. The ab- 
sence of synaptotagmin I and synaptophysin, both implicated 
in Ca2+-dependent exocytosis [16,17,27], is consistent with a 
cAMP-triggered, Ca2+-independent xocytosis in renal epithe- 
lial cells. In neurons Rab3a requires apresumably CaZ+-binding 
protein, rabphilin 3a, to be linked to Ca2+-triggered xocytosis 
[28]. It is intriguing to speculate that principal cells express a 
rabphilin 3a homolog regulated by cAMP/PKA. 
Rab5 proteins are involved in the fusion of early endosomes 
and vesicle recycling [11], whereas proteins of the Rab3 family 
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have been implicated in exocytosis. Recent data demonstrate 
an overlap between Rab5 or Rab3a-containing compartments 
and point to a stage-specific association of Rab5 and Rab3a 
proteins with synaptic vesicles [13]. Hence, the detection of both 
Rab3- and Rab5a-like proteins in our preparation suggests that 
the purification yields either (a) AQP-CD-containing vesicles 
from different parts of a recycling compartment, carrying one 
or the other protein, or (b) vesicles carrying both. The observa- 
tion that in contrast o Rab3 - Rab5a is not enriched with 
AQP-CD does not preclude the presence of Rab5a on AQP-CD 
containing vesicles, as we cannot distinguish between the differ- 
ent stages of recycling vesicles. Similar considerations may 
apply to the vesicular distribution of cellubrevin, a component 
of the ubiquitous regulated and constitutive pathways of endo- 
cytosing and recycling receptors [22]. 
The present report provides structural evidence that vaso- 
pressin-induced antidiuresis i similar to regulated exocytosis 
in neuronal and non-neuronal secretory cells. The identification 
of Rab3-, Rab5a- and synaptobrevin II-like proteins in the 
kidney may be a first step towards understanding the molecular 
mechanisms underlying the antidiuretic action of vasopressin. 
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